Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06105606 · ClinicalTrials.gov registry record · NA
Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions
A NA study of Airway Obstruction and Central Airway Obstruction, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06105606: Recruiting NA study of Airway Obstruction and Central Airway Obstruction, sponsored by Beth Israel Deaconess Medical Center.
NCT06105606 is a NA study of Airway Obstruction and Central Airway Obstruction that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 10 participants, below the 81-participant average among 4 other Airway Obstruction trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06105606, a NA study of Airway Obstruction and Central Airway Obstruction, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to evaluate the feasibility of the AveCure Flexible Microwave destruction of tissue (Ablation) Probe for the treatment of malignant central airway obstruction using a thin, tube-like instrument with a light and a lens for viewing and removing tissue (bronchoscopic). The name of the intervention being used in this research study is: AveCure Flexible Microwave Ablation Probe (handheld, surgical device that delivers microwave energy via flexible probe tip)
Primary Outcome
Feasibility of the AveCure microwave technology to ablate a target malignant central and lobar airway lesions causing \> 50% obstruction, defined as at least 9/10 of the planned ablations (90%) successfully performed bronchoscopically according to the study protocol
Conditions Studied
Interventions
- DEVICE AveCure Flexible Microwave Ablation Probe
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT06105606 shows while recruiting
NCT06105606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 81-participant average among 4 other Airway Obstruction trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Airway Obstruction appearing as the primary indexed condition, and to 1 intervention - of which AveCure Flexible Microwave Ablation Probe is the first listed.
NCT06105606 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06105606 about?
NCT06105606 is a clinical study titled "Feasibility of the AveCure Microwave Ablation Technology for the Bronchoscopic Treatment of Malignant Central Airway Obstructions". This research is being done to evaluate the feasibility of the AveCure Flexible Microwave destruction of tissue (Ablation) Probe for the treatment of malignant central airway obstruction using a thin, tube-like instrument with a light and a lens for viewing and removing tissue (bronchoscopic). The ...
What is the current status of trial NCT06105606?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-03-08. Estimated completion is 2027-01-31.
What conditions does trial NCT06105606 study?
This clinical trial studies the following conditions: Airway Obstruction, Central Airway Obstruction.
What interventions are being tested in trial NCT06105606?
The interventions under investigation include: AveCure Flexible Microwave Ablation Probe (DEVICE).
Who is sponsoring clinical trial NCT06105606?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06105606 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Airway Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE
RECRUITING · NA
-
Anti-Snoring Appliances and Airway Manipulation in Patients Undergoing Anesthetic Sedation
COMPLETED · NA
-
SureCRIC Standardized Patient Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI